13F-HR filed by Artia Global Partners LP
Artia Global Partners LP filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 35 holding rows worth $395,095,066.
- Accession
- 0001937964-25-000004
- Filer
- CIK 1937964
- Filed
- 2025-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2025
A holdings report, 38 entries on the cover page, a total value of $395,095,066 stated on the cover page (in dollars after the unit check, H1), rows summing to $395,095,066 with VALUE read as dollars as filed, 13F file number 028-23071. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 532457108 | COM | 94,887 | $78,368,122 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 45,000 | $37,165,950 | dollars as filed | put |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 498,473 | $35,615,896 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 538,488 | $34,188,603 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 219,719 | $28,985,330 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 318,239 | $24,278,453 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 424,640 | $17,873,098 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 333,851 | $16,145,034 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 229,085 | $15,027,976 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 190,752 | $14,020,272 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 129,700 | $13,084,136 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 136,900 | $9,781,505 | dollars as filed | put |
| QUEST DIAGNOSTICS INC COM | 74834L100 | Stock | 56,717 | $9,596,516 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 28,600 | $7,722,572 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 100,000 | $7,145,000 | dollars as filed | call |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 11,311 | $6,694,585 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 90,745 | $6,435,635 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 172,185 | $5,535,748 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 104,190 | $3,684,158 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 50,000 | $2,648,500 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 53,930 | $2,379,931 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 90,279 | $2,180,238 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 160,000 | $2,156,800 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 54,515 | $2,149,526 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 3,500 | $1,733,445 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 316,700 | $1,716,514 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 14,700 | $1,625,820 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 5,000 | $1,541,350 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 40,000 | $1,342,000 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 7,440 | $1,159,598 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 38,100 | $1,028,700 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 421,359 | $948,058 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 30,900 | $553,728 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 35,226 | $506,550 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 7,380 | $75,719 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001937964-25-000004 | this filing | 2025-05-15 | acceptance time not in the bulk data set |